KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Receivables - Other: 2020-2024

Historic Receivables - Other for Ginkgo Bioworks Holdings (DNA) over the last 4 years, with Dec 2024 value amounting to $11.3 million.

  • Ginkgo Bioworks Holdings' Receivables - Other rose 38.27% to $11.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.2 million, marking a year-over-year increase of 38.27%. This contributed to the annual value of $11.3 million for FY2024, which is 11.88% up from last year.
  • Per Ginkgo Bioworks Holdings' latest filing, its Receivables - Other stood at $11.3 million for FY2024, which was up 11.88% from $10.1 million recorded in FY2023.
  • In the past 5 years, Ginkgo Bioworks Holdings' Receivables - Other ranged from a high of $11.3 million in FY2024 and a low of $4.6 million during FY2021.
  • In the last 2 years, Ginkgo Bioworks Holdings' Receivables - Other had a median value of $10.7 million in 2023 and averaged $10.7 million.
  • Its Receivables - Other has fluctuated over the past 5 years, first dropped by 11.78% in 2021, then grew by 11.88% in 2024.
  • Ginkgo Bioworks Holdings' Receivables - Other (Yearly) stood at $5.2 million in 2020, then decreased by 11.78% to $4.6 million in 2021, then reached $10.1 million in 2023, then grew by 11.88% to $11.3 million in 2024.